LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Accueil・Liste d'Actions・Globus Medical Inc (Class A)

Globus Medical Inc (Class A)

Fermé

Secteur Soins de santé

74.97 1.68

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

74.7

Max

75.28

Chiffres clés
By Trading Economics
Revenu	39M 32M
Ventes	23M 630M
P/E Moyenne du Secteur	126.83 104.138
BPA	0.75
Marge bénéficiaire	5.044
Employés	5,000
EBITDA	43M 128M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+6.28 upside

Dividendes
By Dow Jones
Prochains Résultats	5 nov. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	56M 10B
Ouverture précédente	73.29
Clôture précédente	74.97

Sentiment de l'Actualité

By Acuity

20%

80%

45 / 390 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

73.49 / 75.07 Support & Résistance

Globus Medical Inc (Class A) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 nov. 2024, 23:05 UTC

Actualités

Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks

3 nov. 2024, 21:12 UTC

Résultats

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update

3 nov. 2024, 20:59 UTC

Résultats

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects

3 nov. 2024, 23:16 UTC

Résultats

Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com

3 nov. 2024, 22:50 UTC

Acquisitions, Fusions, Rachats

Santos Says Working Interest in PNG LNG Now 39.9%

3 nov. 2024, 22:50 UTC

Acquisitions, Fusions, Rachats

Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake

3 nov. 2024, 22:49 UTC

Acquisitions, Fusions, Rachats

Santos Says Final Payment Takes Total Cash Consideration to $602 Million

3 nov. 2024, 22:49 UTC

Acquisitions, Fusions, Rachats

Santos Receives Final $241 Million Payment From Kumul

3 nov. 2024, 22:48 UTC

Acquisitions, Fusions, Rachats

Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Deposits Increased 5% to A$674 Billion

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Loans Increased 4% to A$807 Billion

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Impairment Charges 7 Bps of Loans

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items

3 nov. 2024, 20:36 UTC

Résultats

Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%

3 nov. 2024, 20:35 UTC

Résultats

Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps

3 nov. 2024, 20:35 UTC

Résultats

Westpac Raises Share Buyback Program by A$1 Billion

3 nov. 2024, 20:35 UTC

Résultats

Westpac Final Dividend A$0.76/Share

3 nov. 2024, 20:33 UTC

Résultats

Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%

3 nov. 2024, 20:32 UTC

Résultats

Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023

3 nov. 2024, 20:32 UTC

Résultats

Westpac FY Net Profit A$6.99 Billion, Down 3%

3 nov. 2024, 10:30 UTC

Actualités

Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ

3 nov. 2024, 03:00 UTC

Actualités

Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ

2 nov. 2024, 13:53 UTC

Actualités

Résultats

Acquisitions, Fusions, Rachats

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2 nov. 2024, 13:44 UTC

Résultats

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 13:00 UTC

Actualités

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2 nov. 2024, 12:58 UTC

Résultats

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 12:48 UTC

Actualités

Résultats

Acquisitions, Fusions, Rachats

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2 nov. 2024, 12:32 UTC

Résultats

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2 nov. 2024, 12:28 UTC

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 12:17 UTC

Résultats

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

Comparaison

Variation de prix

Globus Medical Inc (Class A) prévision

Objectif de Prix

By TipRanks

6.28% hausse

Prévisions sur 12 Mois

Moyen 79.58 USD 6.28%

Haut 100 USD

Bas 55 USD

Basé sur 15 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

15 ratings

Achat

Maintien

Vente

Basé sur 15 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

73.49 / 75.07Support & Résistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Sentiment

By Acuity

45 / 390Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

À Propos Globus Medical Inc (Class A)

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.